THR-123, a novel BMP-7 mimetic that activates Akt phosphorylation and inhibits cardiomyocyte apoptosis and inflammation, protects the heart from myocardial injury in a Rat model - Scorecard - MDSpire

THR-123, a novel BMP-7 mimetic that activates Akt phosphorylation and inhibits cardiomyocyte apoptosis and inflammation, protects the heart from myocardial injury in a Rat model

  • By

  • Dattatreyamurty Bosukonda

  • Romesh R. Subramanian

  • Peter C. Keck

  • Philippe Bey

  • Frederic R. Carlson

  • William D. Carlson

  • June 25, 2026

  • 0 min

Share

Clinical Scorecard: THR-123: A Novel BMP-7 Mimetic That Enhances Akt Phosphorylation and Reduces Cardiomyocyte Apoptosis and Inflammation, Offering Protection Against Myocardial Damage in a Rat Model

At a Glance

CategoryDetail
ConditionAcute Myocardial Infarction (AMI)
Key MechanismsActivates BMP signaling pathway, enhances Akt phosphorylation, inhibits inflammation and apoptosis.
Target PopulationPatients with myocardial infarction and ischemia-reperfusion injury.
Care SettingClinical research and pharmacological intervention.

Key Highlights

  • THR-123 significantly decreased myocardial infarct size by 84%.
  • Demonstrated anti-inflammatory and anti-apoptotic effects in cardiomyocytes.
  • Promotes tissue regeneration without inducing bone formation.

Guideline-Based Recommendations

Diagnosis

  • Monitor for signs of myocardial infarction and ischemia-reperfusion injury.

Management

  • Consider BMP-7 mimetics like THR-123 for myocardial protection.

Monitoring & Follow-up

  • Assess myocardial infarct size and inflammation levels post-treatment.

Risks

  • Potential for adverse remodeling and heart failure following myocardial infarction.

Patient & Prescribing Data

Patients experiencing acute myocardial infarction.

THR-123 may provide a novel pharmacological intervention to limit myocardial damage.

Clinical Best Practices

  • Utilize BMP-7 signaling pathways for therapeutic strategies in myocardial injury.
  • Monitor cardiomyocyte health and inflammation levels in patients post-MI.

Related Resources & Content

Original Source(s)

Related Content